Marina Mascort, Author at mark'ennovy Australia

Interventions for myopia have evolved significantly in recent years, with multiple options that have demonstrated comparable results: specific ophthalmic lenses, soft contact lenses, overnight orthokeratology and atropine. However, beyond clinical efficacy, current evidence points to a decisive factor: the patient’s visual experience is what determines whether a treatment is maintained over time. And without continuity, no method can deliver its true potential.

Myopia, one of the most prevalent vision conditions in the world, not only affects quality of life, but can also carry serious risks to eye health if not properly controlled. In this article we will explore the efficacy of our MYLO and MYLO Toric lenses in the management of myopia, supported by an independent study conducted by Sergio Diaz, DOO, Mtr. of four and two years respectively.